UC Davis and Orgenesis are rolling out processing units that allow cell and gene therapies to be developed and manufactured onsite. This will increase patient access to therapies.
Nephrology researchers are shining a light on chronic kidney disease as they investigate treatment options for impaired physical performance in chronic kidney disease patients.
A UC Davis MIND Institute researcher is testing a new framework aimed at helping more people with autism and intellectual disabilities find success with employment.
In an article published in The New England Journal of Medicine, UC Davis Health cardiologists share findings that show transcatheter edge-to-edge repair helped patients with tricuspid regurgitation.
UC Davis Health is hosting COVID-19 community testing sites where uninsured patients who test positive can get immediate access to a medical provider via telehealth.
National Cancer Survivors Day celebrated people who survived cancer, or are currently in treatment as well as the family members, doctors and nurses who care for them.
UC Davis Comprehensive Cancer Center leader and breast cancer researcher Laura Fejerman is the inaugural holder of the Placer Breast Cancer Endowed Chair.
We asked Dean Blumberg, chief of pediatric infectious diseases, what we need to know about the additional dose of COVID vaccine, recently approved by the CDC.
